Programmable RNA N 1 ‐Methyladenosine Demethylation by a Cas13d‐Directed Demethylase
N 1 ‐methyladenosine (m 1 A) is a prevalent and reversible RNA modification, which plays a crucial role in the regulation of RNA fate and gene expression. However, the lack of tools to precisely manipulate m 1 A sites in specific transcripts has hindered efforts to clarify the association between a...
Gespeichert in:
Veröffentlicht in: | Angewandte Chemie International Edition 2021-09, Vol.60 (36), p.19592-19597 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | N
1
‐methyladenosine (m
1
A) is a prevalent and reversible RNA modification, which plays a crucial role in the regulation of RNA fate and gene expression. However, the lack of tools to precisely manipulate m
1
A sites in specific transcripts has hindered efforts to clarify the association between a specific m
1
A‐modified transcript and its phenotypic outcomes. Here we develop a CRISPR‐Cas13d‐based tool called
re
engineered m
1
A
mo
dification
v
alid
er
aser (termed “REMOVER”) for targeted m
1
A demethylation of a specific transcript. The catalytically inactive RfxCas13d (dCasRx) is fused to the m
1
A demethylase ALKBH3, and the dCasRx‐ALKBH3 fusion protein can mediate potent demethylation of m
1
A‐modified RNAs. We further find that REMOVER can specifically demethylate m
1
A of MALAT1 and PRUNE1 RNAs, thereby significantly increasing their stability. Our study establishes REMOVER as a tool for targeted RNA demethylation of specific m
1
A‐modified transcripts, which enables further elucidation of the relationship between m
1
A modification of specific transcripts and their phenotypic outcomes. |
---|---|
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.202105253 |